Valuation: Augmedix, Inc.

Market Cap 116M 101M 94.39M 86.34M 163M 11.06B 165M 1.1B 433M 5.53B 436M 427M 18.4B P/E 2022
-2.39x
P/E 2023 -13.4x
Enterprise Value 95.78M 83.12M 77.83M 71.2M 134M 9.12B 136M 911M 357M 4.56B 360M 352M 15.17B EV / Sales 2022
1.75x
EV / Sales 2023 5.88x
Free-Float
99.74%
Yield 2022 *
-
Yield 2023 -
3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 2024-10-01
Director of Finance/CFO - 2024-10-01
Chief Operating Officer - 2024-10-01
Director TitleAgeSince
Director/Board Member 63 2023-04-09
Director/Board Member - 2024-10-01
Date Insider Type Main position Quantity % Market Cap.
10/2/24 Issuer sale

Chief Financial Officer

754,058 1.5256%
10/2/24 Issuer sale

Director

74,230 0.1502%
10/2/24 Issuer sale

Director

93,047 0.1882%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-41.54% 116M
+0.37%-2.24%-9.87%+64.99% 80.59B
-3.10%-15.76%-14.81%+58.38% 17.71B
-0.44%+8.50%-1.99%+13.20% 16.93B
0.00%+1.90%+6.84%+13.62% 14.58B
0.00%+0.09%+25.54%+37.02% 12.07B
-1.53%+6.92%+26.05%+93.35% 8.24B
-0.14%-3.83%+52.49%+101.79% 6.83B
+2.52%+2.35%-14.31%-0.19% 5.98B
+0.58%+2.08%+21.13%+1.18% 5.51B
Average -0.19%-1.11%+9.11%+34.18% 16.86B
Weighted average by Cap. -0.17%-3.85%-0.47%+51.06%

Financials

2022 2023
Net sales 30.93M 26.84M 25.14M 22.99M 43.41M 2.95B 43.97M 294M 115M 1.47B 116M 114M 4.9B 44.86M 38.93M 36.45M 33.34M 62.94M 4.27B 63.77M 426M 167M 2.13B 168M 165M 7.11B
Net income -24.45M -21.22M -19.87M -18.17M -34.31M -2.33B -34.76M -232M -91.21M -1.16B -91.8M -89.8M -3.87B -19.17M -16.64M -15.58M -14.25M -26.9M -1.83B -27.25M -182M -71.52M -912M -71.98M -70.42M -3.04B
Net Debt -4.28M -3.71M -3.48M -3.18M -6M -407M -6.08M -40.66M -15.96M -204M -16.06M -15.71M -678M -20.37M -17.68M -16.55M -15.14M -28.59M -1.94B -28.96M -194M -76M -970M -76.48M -74.82M -3.23B
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock